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Introduction: DILI differs across geographical areas due to differen-
tial drug polices, prescription habits, drug consumption, and genetic 
factors. In this study, we have compared DILI cases included in the 
recently established Latin American DILI Network with those in 
the Spanish DILI Registry and the US Drug-Induced Liver Injury 
Network to identify differences in phenotypic presentations and 
causative agents.
Patients (or Materials) and Methods: Demographic, clinical 
parameters, and causative agents were compared between 98 Latin 
American, 851 Spanish, and 300 US DILI cases.
Results: The Latin American cases had a mean age of 54 years with 
a predominance of females (61%), whereas mean age and female 
proportion in the Spanish and US DILI cases were 54 years with 49% 
females and 48 years with 60% females, respectively. The most com-
mon type of liver damage in all 3 registries was hepatocellular injury. 
Jaundice was frequently seen in the registries, with 70%, 66%, and 
69% of the Latin American, Spanish, and US DILI cases, respectively. 
Hospitalization occurred in 51% of the Latin American DILI cases, 
with 57% and 60% of the Spanish and US cases requiring hospi-
talization. Liver-related death or liver transplantation occurred in 
5.1%, 3.6%, and 6.0% of the Latin American, Spanish, and US cases, 
respectively. The main causative agents in Latin America included 
nimesulide, diclofenac, nitrofurantoin, cyproterone acetate, and vari-
ous herbal remedies, whereas amoxicillin-clavulanate predominated 
in the other 2 registries, followed by ibuprofen in Spain and nitro-
furantoin in the United States.
Conclusion: The Latin American DILI cases demonstrate similar 
phenotypic characteristics as observed in registers outside Latin 
America with respect to type of injury and severity. Female sex 
predominates in the Latin America and US registries. With regard 
to causative agents, elevated representation of NSAIDs, hormonal 
treatments, and herbal remedies were seen in Latin America, whereas 
antibiotics were more common causes of DILI in Spain and the 
United States.
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Introduction: We report a case of cefepime intoxication with acute 
severe neurologic symptoms, which was treated by temporary hemo-
dialysis.
Patients (or Materials) and Methods: Cefepime 2 g BID for endo-
vascular prosthesis infection was prescribed to a frail, chronically ill 
88-year-old woman with a serum creatinine of 199 µmol/L and an 
estimated creatinine clearance of 13 mL/min (Cockroft formula). Two 
days later, she was transferred to a neurocritical care unit because 
of acute aphasia, myoclonic jerks, and delirium with a Glasgow 
coma scale score of 12/15. The following day, in the absence of 
other causes, cefepime intoxication was hypothesized, and cefepime 
was withdrawn after a total of 7 doses = 14 g. Over the next 24 
hours, two 3-hour hemodialysis (HD) sessions were performed under 
cefepime concentration monitoring.
Results: Cefepime plasma levels were measured by liquid chroma-
tography/mass spectrometry. There is no validated reference range, 
but a study (Chapuis T et al, Critical Care, 2010) found a 50% risk 
of neurotoxicity with residual levels > 15 mg/L. In our patient, levels 
were 83.3 mg/L 10 hours after last dose, 24.1 mg/L immediately after 
the first HD session, 13.4 mg/L immediately before the second HD 
session, and 2.5 mg/L immediately after the second HD session. The 
patient made a full clinical recovery over the next 48 hours. The 70% 
to 80% fall in plasmatic levels observed during each HD session is 
in accordance with literature data (Schmaldienst S et al, Eur J Clin 
Pharmacol, 2000, and Manyor LM et al, Pharmacotherapy, 2008). 
According to kinetic simulation, cefepime dropped at a concentration 
< 15 mg/L 15 hours earlier with HD than it would have without.
Conclusion: Neuropsychiatric adverse effects of beta-lactam antibi-
otics can be easily overlooked by clinicians. One should be especially 
cautious with their use in very old and frail patients in whom plasma 
creatinine poorly estimates renal function and cognitive impair-
ment is highly prevalent. Temporary hemodialysis effectively clears 
cefepime, but its role in hastening clinical recovery may be limited.
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Introduction: Hospitalization due to adverse drug events (ADE) is a 
well-known problem. According to the literature ADE are the reason 
for ~5% of hospitalizations. Recent pharmacoepidemiologic studies 
raised concern regarding the long-term safety of antipsychotic and 
antidepressant drugs. It was the aim to analyze the involvement of 
psychotropic drugs in ADE of patients presenting at an emergency 
department (ED).
Patients (or Materials) and Methods: In this prospective observa-
tional study, nontraumatic patients presenting at the ED of a tertiary 
care university teaching hospital were evaluated in 3 study phases by 
intensive chart review by an interdisciplinary expert panel to detect 
and classify all ADE.
